semaglutide discovery Novo cuts GLP-1 prices 70%, but revenue could grow in 2026 30 years of obesity research

A systematic review and meta-analysis in eClinicalMedicine, pooling fourteen studies, found that GLP-1 receptor agonists, particularly semaglutide and liraglutide, were associated with reduced alcohol consumption, lower relapse rates, and fewer alcohol-related diagnoses

In a cohort of over 150,000 patients, the researchers identified no difference in the risk following initiation of different GLP-1 agents among these adults, despite the differences in systemic efficacy among the examined GLP-1 receptor agonist medications

If you're someone who eats a substantial breakfast, that can also be an appropriate time to take your daily dose

Discoveries like this simply would not exist without our research participants

He is a researcher at the Cleveland Clinic Center for Value-Based Care Research.People taking the drugs in real-world settings appear to be more likely to quit taking the meds, researchers said

Shortages might lead to treatment delays, which can hurt patients dealing with time-sensitive conditions like cancer